University of Illinois at Chicago
Exemption #JDR443
Announcement of an Exempt Purchase
Award Info Published Thursday February 13, 2025
Guerbet LLCPrinceton, NJ
- Amount: An estimated $1,000,000
- Terms: An estimated start date of 7/1/2025 through 6/30/2029
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed as this award goes through a state approval process.
First published Thursday, February 13, 2025
The University awarded a contract for Lipiodol (ethiodized oil) Injection.
Lipiodol (ethiodized oil) injection is an oil-based radio-opaque contrast agent indicated for selective hepatic intra-arterial use in adults with hepatocelluar carcinoma. It is combined with chemotherapeutic agents and then injected into the hepatic artery to treat hepatocellular carcinoma.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5)) If we are unable to purchase Lipiodol, UI Health will not be able to provide this life saving treatment and patients will have to be referred to other medical centers, resulting in a loss of revenue.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.